【st peter's fiesta gloucester 2024 schedule time pdf】Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
Cytokinetics (CYTK) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.42. This st peter's fiesta gloucester 2024 schedule time pdfcompares to loss of $0.48 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -23.81%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.56 per share when it actually produced a loss of $0.50, delivering a surprise of 10.71%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Cytokinetics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $5.21 million for the quarter ended December 2019, missing the Zacks Consensus Estimate by 27.51%. This compares to year-ago revenues of $9.38 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Cytokinetics shares have added about 34.2% since the beginning of the year versus the S&P 500's decline of -4.4%.
What's Next for Cytokinetics?
While Cytokinetics has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Cytokinetics was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.48 on $7 million in revenues for the coming quarter and -$2.03 on $27.80 million in revenues for the current fiscal year.
Story continues
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
Cytokinetics, Incorporated (CYTK) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
View comments
-
Rental fleet collapse drags down U.S. vehicle salesBRIEF-Bright Real Estate's Unit Wins Land Auction For 293.2 Million Yuan In Yunnan ProvinceCoral Gables Office Building Trades for Nearly $2 MillionProsecutor drops insider trading case against former Deutsche Boerse CEOFrom wagyu beef to melons, Japan's $2.2 trillion virus rescue piques struggling firmsProphecy Starts District Exploration at PulacayoNissan's First US-Market Car Was More British Than JapaneseEuro zone factories ended 2018 on a low note - PMIIs Begbies Traynor Group plc's (LON:BEG) High P/E Ratio A Problem For Investors?Starting in 2019, You Won't Get a $7500 Tax Credit on a New Tesla
下一篇:WhatsApp no longer supported on millions of phones
- ·Why Consumer Financial Protection Bureau's structure is a real threat to small business, individual liberty
- ·Google wins U.S. approval for new radar-based motion sensor
- ·Should You Be Concerned About Shougang Concord Grand (Group) Limited’s (HKG:730) Historical Volatility?
- ·What to Watch Tuesday: Mindy Returns, Cougar Town Finale, @CraigyFerg Hosts TPIR and More
- ·GBP/JPY Price Forecast – Pound Continues to Grind Away at Resistance
- ·RBI to allow banks to restructure some defaulting small business loans
- ·Should Union Bankshares Corporation (NASDAQ:UBSH) Be Part Of Your Dividend Portfolio?
- ·Prince Harry and Meghan Markle's Engagement Might Have Been Predicted in Love, Actually
- ·Romios Completes 2020 Field Work in the Golden Triangle, Identifies Strong Alteration Zones at Recent Copper-Gold Discoveries on its TREK SOUTH and ANDREI EAST Porphyry Targets
- ·Another number paints a bleak picture of manufacturing in China
- ·UK Manufacturing PMI Hits 6-Month High on Brexit Boost
- ·Record Speculative Longs and Hedger Shorts in Silver
- ·2 Beaten-Up Penny Stocks That Are Set for a Rebound
- ·3 Hotel Stocks Likely to Beat Estimates in Q1 Earnings
- ·Arconic shares jump after report of buyout by Apollo Global
- ·Former Judge Randy Wilson Returns to Susman Godfrey After 15 Years on Bench
- ·Fiat Chrysler postpones shareholders' meeting and resolution on dividend to late June
- ·Samsung Heavy to absorb Samsung Engineering for $2.5 billion
- ·Apple cuts forecast, citing weak China sales amid trade tensions
- ·Why the Fed will keenly watch the purchasing managers releases
- ·GREATERGOOD.ORG ANNOUNCES “THANK YOUR TEACHER” CHALLENGE ON THE NEW GIRLS’ VOICES AT HOME PLATFORM
- ·BRIEF-Vpower Group International Says Power Plant Commences Commercial Operation
- ·What Kind Of Investor Owns Most Of Morguard Real Estate Investment Trust (TSE:MRT.UN)?
- ·BRIEF-Kasen International Holdings Says Expected To Record Consol Net Profit Attributable For Year
- ·Is MYR Group (MYRG) a Great Value Stock Right Now?
- ·GLOBAL MARKETS-Asian shares off 4-month high as China data disappoints
- ·One Spark Networks SE (NYSEMKT:LOV) Broker Analyst Just Cut Their Revenue Numbers By 15%
- ·Wiseway Group Limited (ASX:WWG) Is Employing Capital Very Effectively
- ·Pompeo, Brazil foreign minister discuss democracy support for Cuba, Venezuela, Nicaragua
- ·Honeywell Earnings, Revenue beat in Q4
- ·Euro Sun Mining Announces the Filing of a Business Acquisition Report in Connection with its Acquisition of Vilhelmina Minerals Inc.
- ·This Original Movie Is a Smash Hit for Netflix
- ·Connecticut's Fiscal Problems Require a Full-Court Press
- ·Takeover target RPC posts flat profit, to stockpile ahead of Brexit
- ·Paycheck Protection Program (PPP) Loans
- ·Activision Blizzard plans to terminate CFO Neumann